2015
DOI: 10.1177/1362361315608323
|View full text |Cite
|
Sign up to set email alerts
|

Should all young children be screened for autism spectrum disorder?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
22
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(26 citation statements)
references
References 4 publications
2
22
0
Order By: Relevance
“…For example, the US Preventative Services Task Force (USPSTF) concluded that there was “insufficient evidence to recommend screening for ASD in children aged 18 months to 30 months for whom no concerns of ASD have been raised,” defining critically needed evidence as “large, high-quality cluster randomized clinical trials of treatment that enroll young children with ASD identified through screening.”135 However, screening (for example, using M-CHAT) has been shown to have predictive validity (as acknowledged by the USPSTF135), identifies ASD symptoms earlier and more consistently than general inquiry about parent concerns110117 (an alternative strategy recommended by the USPSTP135), may reduce disparities in access to diagnostic services,136 and accelerates the pathway to accessing specialized interventions that improve outcomes 135137. Thus, some have argued that screening is warranted on the basis of the balance between potential risks and benefits, even in the absence of evidence from randomized controlled trials (RCTs) 138139140. Ultimately, estimates of sensitivity and specificity as well as changes in age of diagnosis and access to intervention are needed to fully evaluate the systems impact of ASD screening.…”
Section: Screening and Surveillancementioning
confidence: 99%
“…For example, the US Preventative Services Task Force (USPSTF) concluded that there was “insufficient evidence to recommend screening for ASD in children aged 18 months to 30 months for whom no concerns of ASD have been raised,” defining critically needed evidence as “large, high-quality cluster randomized clinical trials of treatment that enroll young children with ASD identified through screening.”135 However, screening (for example, using M-CHAT) has been shown to have predictive validity (as acknowledged by the USPSTF135), identifies ASD symptoms earlier and more consistently than general inquiry about parent concerns110117 (an alternative strategy recommended by the USPSTP135), may reduce disparities in access to diagnostic services,136 and accelerates the pathway to accessing specialized interventions that improve outcomes 135137. Thus, some have argued that screening is warranted on the basis of the balance between potential risks and benefits, even in the absence of evidence from randomized controlled trials (RCTs) 138139140. Ultimately, estimates of sensitivity and specificity as well as changes in age of diagnosis and access to intervention are needed to fully evaluate the systems impact of ASD screening.…”
Section: Screening and Surveillancementioning
confidence: 99%
“…It is known that receiving a diagnosis of ASD greatly affects the child and his/her parents: indeed, the diagnosis can yield some beneficial effects [ 8 , 9 ], but it can also be associated with risks, disadvantages, and contraindications [ 10 , 11 , 12 ]. Concerning the consequences of an ASD diagnosis, both parents and clinicians expect an effective intervention once a diagnosis is given [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…[ 1 ] However, the actual estimates are substantially higher as there is no surveillance mechanism to ensure universal reporting of each of these cases, especially in low- and middle-income nations. [ 4 ] Further, the epidemiological studies performed in the last couple of decades have shown confirmatory evidence to suggest a rise in the prevalence of ASDs across the world. [ 4 5 ] Different reasons such as an increase in the level of awareness, expansion of the diagnostic criteria, improvement in the diagnostic tools and reporting, have been identified for the eventual rise in the prevalence of ASDs.…”
mentioning
confidence: 98%
“…[ 1 5 ] In addition, measures such as counseling family members about the different aspects of the disease, its prognosis, and types of services available; offering behavior therapy to negate the concerns of difficulty in communication and impairment of the social behavior; ensuring accessibility and availability of comprehensive package of services, including health promotion, rehabilitation and care services; formulating policies to enable coordination between different sectors to safeguard education or employment options of the affected persons; and supporting the above measures with broader measures to make the country's infrastructure more accessible, inclusive, and supportive. [ 1 4 5 6 7 ]…”
mentioning
confidence: 99%